The CBF Study Evaluating the Effect of Betahistine on the Cerebral Blood Flow

Clinical trial NCT01468285 · COMPLETED

Trial details

NCT number: NCT01468285
Sponsor: Abbott Products
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Gait or Balance Disorder Problems

Start date: 2012-02-01
Primary completion: 2013-04-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.